cancer-therapy

Documents about cancer-therapy

• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics#651923Europe PMC
• Impact of donor substituents on photodynamic therapy performance: Comparative in vitro evaluation of NSeAze and NSeMorph in glioblastoma#200816OpenMETU
• Patterns of practice for breast cancer post-operative radiation therapy in Italy according to the ESTRO-ACROP consensus and AIRO position paper: a national survey on the behalf of the Italian association of radiotherapy and clinical oncology (AIRO)#250577IRIS
• A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer#460010ClinicalTrials.gov
• Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer#644306IRIS
• Impact of first-line immunotherapy on survival and intracranial outcomes from a real-world cohort of patients with non-small cell lung cancer with brain metastases at diagnosis.#676991HAL (France)
• Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection#148725ClinicalTrials.gov
• Unscheduled bleeding and endometrial cancer in women on postmenopausal hormone replacement therapy and their matched controls: protocol for a descriptive cohort study using the Orchid-e database#192365bioRxiv / medRxiv
• Metabolic profiling and systems biology analysis of Flammulina filiformis Fv19 extract: an integrated computational and experimental approach for dual anti-cancer and immunomodulatory therapy.#221043NCBI PubMed Central
• Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)#261506ClinicalTrials.gov
• The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.#266983NCBI PubMed Central
• Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier#312097HAL (France)
• Exploring the Experiences of Cancer Patients Following an Internet-Based Cognitive Behavioral Therapy for Insomnia With Professional Phone Guidance: The Sleep-4-All-2.0 Study.#320394NCBI PubMed Central
• Exploring the Experiences of Cancer Patients Following an Internet‐Based Cognitive Behavioral Therapy for Insomnia With Professional Phone Guidance: The Sleep‐4‐All‐2.0 Study#326302HAL (France)
• Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial#370715HAL (France)
• Strengthening the shield: Cognitive behavioral therapy as a critical adjunct in ovarian cancer chemotherapy - Evidence from a systematic review and meta-analysis of randomized controlled trials.#371317NCBI PubMed Central
• The emerging roles of artificial intelligence in cancer drug development and precision therapy#421626OpenAlex
• Supplemental Material for: Rapid Regression of Choroidal Metastasis Under First-Line Osimertinib Therapy in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report#436092Figshare
• Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors#450644S-Space: Seoul National University
• Communication-related aspects drive senior patients’ satisfaction with the process of decision-making in cancer therapy#618660Bielefeld Pub
• Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)#677255HAL (France)
• Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma#800299ClinicalTrials.gov
• The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease#410145Scholar Commons
• Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer#429744ClinicalTrials.gov
• Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study.#145825NCBI PubMed Central
• Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU).#161773NCBI PubMed Central
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer#202825Lund University Publications
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors#230496ClinicalTrials.gov
• Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer#238036bioRxiv / medRxiv
• Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma#252976ClinicalTrials.gov
• Vascular Disruption Therapy as a New Strategy for Cancer Treatment#291403Gestión del Repositorio Documental de la Universidad de Salamanca
• Supporting data for "Pt1a and tyrosine kinase inhibitor combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification".#344096Figshare
• Optical coherence tomography assessment of tongue papillary atrophy and patient-reported impact on taste following head and neck cancer therapy#654951Spiral
• Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial#677111HAL (France)
• In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity.#226932HAL (France)
• ASO Visual Abstract: Impact of BRCA mutation status on tumor dissemination pattern, surgical outcome, and patient survival in primary and recurrent high-grade serous ovarian cancer (HGSOC). A multicenter, retrospective study of the ovarian cancer therapy—innovative models prolong survival (OCTIPS) consortium#308507ISTA Publications
• The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):#148769ClinicalTrials.gov
• Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship.#152294NCBI PubMed Central
• 4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC#162465ClinicalTrials.gov
• Rational design of protein switches: applications in synthetic biology and cancer immunotherapy#179003Infoscience
• Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.#232228NCBI PubMed Central
• Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium#370791HAL (France)
• Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical Oncology#406809OSF
• Investigating the protective effects of exercise in cardiotoxic cancer therapy#475602Figshare
• Design and evaluation of a novel peptide-EV complex for targeted Alzheimer’s disease therapy#478479Figshare
• The impact of different exercise modalities on health-related quality of life in patients with prostate cancer undergoing androgen deprivation therapy: a systematic review and network meta-analysis.#631005NCBI PubMed Central
• Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017#338807OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Development and validation of a deep learning radiomics model based on ultrasound and clinical features to predict prognosis in elderly patients with advanced pancreatic cancer after HIFU therapy.#3951NCBI PubMed Central
• A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability#4681Europe PMC
• Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1#146267ClinicalTrials.gov